Luskin A, Griffin NM, Wagele-Steffen A, et al. Decreased exacerbations and hospitalizations in adolescents enrolled in PROSPERO (Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab). ATS 2017, abstract A5104.
Preventieve behandeling voor contacten van patiënten met MDR-tuberculose
jan 2024 | Bacteriële infecties, Tuberculose